Ubiquitination and deubiquitination in cancer: from mechanisms to novel therapeutic approaches
Open accessThe DOI matches its Crossref record; 467 of the 467 references it cites were found in a registry or an index.
Abstract
Ubiquitination, a pivotal posttranslational modification of proteins, plays a fundamental role in regulating protein stability. The dysregulation of ubiquitinating and deubiquitinating enzymes is a common feature in various cancers, underscoring the imperative to investigate ubiquitin ligases and deubiquitinases (DUBs) for insights into oncogenic processes and the development of therapeutic interventions. In this review, we discuss the contributions of the ubiquitin–proteasome system (UPS) in all hallmarks of cancer and progress in drug discovery. We delve into the multiple functions of the UPS in oncology, including its regulation of multiple cancer-associated pathways, its role in metabolic reprogramming, its engagement with tumor immune responses, its function in phenotypic plasticity and polymorphic microbiomes, and other essential cellular functions. Furthermore, we provide a comprehensive overview of novel anticancer strategies that leverage the UPS, including the development and application of proteolysis targeting chimeras (PROTACs) and molecular glues.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Items 201–400 of 467
Identification of New Compounds That Trigger Apoptosome-Independent Caspase Activation and Apoptosis
Aleo, E., Henderson, C. J., Fontanini, A., Solazzo, B., & Brancolini, C. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-0702 · Cited by 119
Deubiquitination of EGFR by Cezanne-1 contributes to cancer progression
Pareja, F. G., Ferraro, D. A., Rubin, C., Cohen‐Dvashi, H., Zhang, F., Aulmann, S., Ben‐Chetrit, N., Pines, G., Navon, R., Crosetto, N., et al. (2011) · Oncogene · doi:10.1038/onc.2011.587 · Cited by 118
Therapeutic potential of Clostridium butyricum anticancer effects in colorectal cancer
Xu, H., Luo, H., Zhang, J., Li, K., & Lee, M. (2023) · Gut Microbes · doi:10.1080/19490976.2023.2186114 · Cited by 117
Self-citationTRAF4 Is a Critical Molecule for Akt Activation in Lung Cancer
Li, W., Peng, C., Lee, M., Lim, D., Zhu, F., Fu, Y., Yang, G., Sheng, Y., Xiao, L., Dong, X., et al. (2013) · Cancer Research · doi:10.1158/0008-5472.can-13-0913 · Cited by 115
Self-citationFBXO22 Possesses Both Protumorigenic and Antimetastatic Roles in Breast Cancer Progression
Sun, R., Xie, H.-Y., Qian, J.-X., Huang, Y.-N., Yang, F., Zhang, F.-L., Shao, Z., & Li, D. (2018) · Cancer Research · doi:10.1158/0008-5472.can-17-3647 · Cited by 115
Sekeres, M. A., Watts, J. M., Radinoff, A., Sangerman, M. A., Cerrano, M., Font, P., Zeidner, J. F., Díez‐Campelo, M., Graux, C., Liesveld, J. L., et al. (2021) · Leukemia · doi:10.1038/s41375-021-01125-4 · Cited by 115
Zhong, L., Liao, D., Li, J., Liu, W., Wang, J., Zeng, C., Wang, X., Cao, Z., Zhang, R., Li, M., et al. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-00414-1 · Cited by 115
Yu, S., Zang, W., Qiu, Y., Liao, L., & Zheng, X. (2021) · Oncogene · doi:10.1038/s41388-021-02071-2 · Cited by 115
Li, X., Stevens, P. D., Yang, H., Gulhati, P., Wang, W., Evers, B. M., & Gao, T. (2012) · Oncogene · doi:10.1038/onc.2012.66 · Cited by 114
Akt is negatively regulated by the MULAN E3 ligase
Bae, S., Kim, S. Y., Jung, J. H., Yoon, Y., Cha, H. J., Lee, H., Kim, K., Kim, J., An, I.-S., Kim, J., et al. (2012) · Cell Research · doi:10.1038/cr.2012.38 · Cited by 114
Johnson, H., Rosario, A. M. D., Bryson, B. D., Schroeder, M. A., Sarkaria, J. N., & White, F. M. (2012) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m112.019984 · Cited by 113
Lee, J.-H., Jung, S. M., Yang, K.-M., Bae, E., Ahn, S. G., Park, J. S., Seo, D., Kim, M., Ha, J., Lee, J., et al. (2017) · Nature Cell Biology · doi:10.1038/ncb3609 · Cited by 112
Zhang, L., Chen, J., Deng, N., Liu, Q., Wang, C., Zhang, Z., Chu, L., Yu, C., Liang, H., Zhang, B., et al. (2019) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-019-1058-6 · Cited by 112
Self-citationFBXO22 degrades nuclear PTEN to promote tumorigenesis
Ge, M.-K., Zhang, N., Li, X., Zhang, C., Dong, S.-S., Li, Z., Ji, Y., Zheng, M., Sun, J. P., Chen, G., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-15578-1 · Cited by 111
Zhu, Y., Zhang, C., Huang, M., Lin, J., Fan, X. M., & Ni, T. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.644901 · Cited by 111
Self-citationM6A RNA Methylation Regulates Histone Ubiquitination to Support Cancer Growth and Progression
Yadav, P., Subbarayalu, P., Medina, D., Nirzhor, S. S. R., Timilsina, S., Rajamanickam, S., Eedunuri, V. K., Gupta, Y. K., Zheng, S., Abdelfattah, N., et al. (2022) · Cancer Research · doi:10.1158/0008-5472.can-21-2106 · Cited by 111
Annual review of PROTAC degraders as anticancer agents in 2022
Wang, X., Qin, Z.-L., Li, N., Jia, M.-Q., Liu, Q.-G., Bai, Y., Song, J., Yuan, S., & Zhang, S. (2024) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2024.116166 · Cited by 111
USP1 targeting impedes GBM growth by inhibiting stem cell maintenance and radioresistance
Lee, J.-K., Chang, N., Yoon, Y., Yang, H., Cho, H., Kim, E., Shin, Y., Kang, W., Oh, Y. T., Mun, G. I., et al. (2016) · Neuro-Oncology · doi:10.1093/neuonc/nov091 · Cited by 110
Yang, F., Xu, J., Li, H., Tan, M., Xiong, X., & Sun, Y. (2019) · Nature Communications · doi:10.1038/s41467-019-09289-5 · Cited by 109
Self-citationFBW7 Mediates Senescence and Pulmonary Fibrosis through Telomere Uncapping
Wang, L., Chen, R., Li, G., Wang, Z., Liu, J., Liang, Y., & Liu, J.-P. (2020) · Cell Metabolism · doi:10.1016/j.cmet.2020.10.004 · Cited by 109
Regulation of RIG-I Activation by K63-Linked Polyubiquitination
Okamoto, M., Kouwaki, T., Fukushima, Y., & Oshiumi, H. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01942 · Cited by 108
Targeting the p53-MDM2 pathway for neuroblastoma therapy: Rays of hope
Zafar, A., Wang, W., Liu, G., Xian, W., McKeon, F., Zhou, J., & Zhang, R. (2021) · Cancer Letters · doi:10.1016/j.canlet.2020.09.023 · Cited by 108
The ubiquitin E3 ligase FBXO22 degrades PD-L1 and sensitizes cancer cells to DNA damage
De, S., Holvey-Bates, E. G., Mahen, K. K., Willard, B. B., & Stark, G. R. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2112674118 · Cited by 108
Venetoclax and idasanutlin in relapsed/refractory AML: a nonrandomized, open-label phase 1b trial
Daver, N. G., Dail, M., Garcia, J. S., Jonas, B. A., Yee, K. W. L., Kelly, K. R., Vey, N., Assouline, S. E., Roboz, G. J., Paolini, S., et al. (2022) · Blood · doi:10.1182/blood.2022016362 · Cited by 108
Pozhidaeva, A., Valles, G., Wang, F., Wu, J., Sterner, D. E., Nguyen, P., Weinstock, J., Kumar, K. G. S., Kanyo, J., Wright, D., et al. (2017) · Cell Chemical Biology · doi:10.1016/j.chembiol.2017.09.004 · Cited by 107 · cited 2×
“USP7 antagonists, such as p5091 and p50429, have been developed to promote the ubiquitination and degradation of MDM2, leading to bortezomib resistance in MM cells [482, 488, 489].”
BackgroundTargeting the BIR Domains of Inhibitor of Apoptosis (IAP) Proteins in Cancer Treatment
Cossu, F., Milani, M., Mastrangelo, E., & Lecis, D. (2019) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2019.01.009 · Cited by 107
Sun, J., Zhu, Z., Li, W., Shen, M., Cao, C., Sun, Q., Guo, Z.-Q., Liu, L., & Wu, D. (2020) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-020-01734-4 · Cited by 107
Deubiquitination of MYC by OTUB1 contributes to HK2 mediated glycolysis and breast tumorigenesis
Han, X., Ren, C., Lü, C., Qiao, P., Yang, T., & Yu, Z. (2022) · Cell Death and Differentiation · doi:10.1038/s41418-022-00971-8 · Cited by 107
Noonan, A. M., Bunch, K. P., Chen, J., Herrmann, M. A., Lee, J., Kohn, E. C., O'Sullivan, C. C., Jordan, E., Houston, N., Takebe, N., et al. (2016) · Cancer · doi:10.1002/cncr.29783 · Cited by 104
Self-citationOtubain 1: a non-canonical deubiquitinase with an emerging role in cancer
Saldana, M., VanderVorst, K., Berg, A. L., Lee, H., & Carraway, K. L. (2018) · Endocrine Related Cancer · doi:10.1530/erc-18-0264 · Cited by 104
Positive feedback between p53 and TRF2 during telomere-damage signalling and cellular senescence
Fujita, K., Horikawa, I., Mondal, A. M., Jenkins, L. M. M., Appella, E., Vojtesek, B., Bourdon, J.-C., Lane, D. P., & Harris, C. C. (2010) · Nature Cell Biology · doi:10.1038/ncb2123 · Cited by 103
Lee, T. H., Perrem, K., Harper, J. W., Lu, K. P., & Zhou, X. Z. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m509855200 · Cited by 103
Xu, J., Zhou, W., Yang, F., Chen, G., Li, H., Zhao, Y., Liu, P., Li, H., Tan, M., Xiong, X., et al. (2017) · Nature Communications · doi:10.1038/ncomms14002 · Cited by 103
Self-citationLambies, G., Miceli, M., Martínez-Guillamon, C., Olivera-Salguero, R., Peña, R., Frías, C.-P., Calderón, I., Atanassov, B. S., Dent, S. Y. R., Arribas, J., et al. (2019) · Cancer Research · doi:10.1158/0008-5472.can-18-0753 · Cited by 99 · cited 1×
“Inhibition of USP27X leads to the destabilization of Snail1, inhibits the EMT process, and enhances the sensitivity of tumor cells to chemotherapy [200].”
BackgroundGounder, M. M., Bauer, T. M., Schwartz, G. K., Weise, A. M., LoRusso, P., Kumar, P., Tao, B., Hong, Y., Patel, P., Lu, Y., et al. (2023) · Journal of Clinical Oncology · doi:10.1200/jco.22.01285 · Cited by 99
Jin, X., Pan, Y., Wang, L., Ma, T., Zhang, L., Tang, A., Billadeau, D. D., Wu, H., & Huang, H. (2017) · Cancer Research · doi:10.1158/0008-5472.can-16-3143 · Cited by 98
Erba, H. P., Becker, P. S., Shami, P. J., Grunwald, M. R., Flesher, D. L., Zhu, M., Rasmussen, E., Henary, H. A., Anderson, A. A., & Wang, E. S. (2019) · Blood Advances · doi:10.1182/bloodadvances.2019030916 · Cited by 98
Xia, X., Liao, Y., Huang, C., Liu, Y., He, J., Shao, Z., Jiang, L., Dou, Q. P., Liu, J., & Huang, H. (2019) · Cancer Letters · doi:10.1016/j.canlet.2019.09.003 · Cited by 98
Kensche, T., Tokunaga, F., Ikeda, F., Goto, E., Iwai, K., & Dikic, I. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.347195 · Cited by 97
Zhao, Y., Conze, D. B., Hanover, J. A., & Ashwell, J. D. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m609146200 · Cited by 96
IBRDC2, an IBR‐type E3 ubiquitin ligase, is a regulatory factor for Bax and apoptosis activation
Bénard, G., Neutzner, A., Peng, G., Wang, C., Livák, F., Youle, R. J., & Karbowski, M. (2010) · The EMBO Journal · doi:10.1038/emboj.2010.39 · Cited by 96
Li, Z., Wang, Y., Li, Y., Yin, W., Mo, L., Qian, X., Zhang, Y., Wang, G., Bu, F., Zhang, Z., et al. (2018) · Cell Death and Disease · doi:10.1038/s41419-018-0451-y · Cited by 96
He, L., Liu, X., Yang, J., Li, W., Liu, S., Liu, X., Yang, Z., Ren, J., Wang, Y., Shan, L., et al. (2018) · Cell Research · doi:10.1038/s41422-018-0079-6 · Cited by 96
Li, X., Liu, H., Zhou, C., Yang, X., Huang, L., Jie, H., Zeng, Z., Zheng, X., Li, W., Liu, Z., et al. (2023) · Molecular Cancer · doi:10.1186/s12943-023-01773-3 · Cited by 96
Self-citationLü, S., Zhou, J., Jian, H., Wu, L., Cheng, Y., Fan, Y., Fang, J., Chen, G., Zhang, Z., Lv, D., et al. (2023) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(23)00183-2 · Cited by 96
Self-citationMRN complex is an essential effector of DNA damage repair
Qiu, S., & Huang, J. (2021) · Journal of Zhejiang University SCIENCE B · doi:10.1631/jzus.b2000289 · Cited by 92
Jiang, Q., Zheng, N., Bu, L., Zhang, X., Zhang, X., Wu, Y., Su, Y., Wang, L., Zhang, X., Ren, S., et al. (2021) · Molecular Cancer · doi:10.1186/s12943-021-01397-5 · Cited by 92
Self-citationA Phase 2 study of perifosine in advanced or metastatic breast cancer
Leighl, N. B., Dent, S. F., Clemons, M. J., Vandenberg, T. A., Tozer, R. G., Warr, D. G., Crump, R. M., Hedley, D. W., Pond, G. R., Dancey, J. E., et al. (2007) · Breast Cancer Research and Treatment · doi:10.1007/s10549-007-9584-x · Cited by 91
Expansion of interferon inducible gene pool via USP18 inhibition promotes cancer cell pyroptosis
Arimoto, K., Miyauchi, S., Troutman, T. D., Zhang, Y., Liu, M., Stoner, S. A., Davis, A. G., Fan, J.-B., Huang, Y.-J., Yan, M., et al. (2023) · Nature Communications · doi:10.1038/s41467-022-35348-5 · Cited by 91
USP2 promotes tumor immune evasion via deubiquitination and stabilization of PD-L1
Kuang, Z., Liu, X., Zhang, N., Dong, J., Sun, C., Yin, M., Wang, Y., Liu, L., Xiao, D., Zhou, X., et al. (2023) · Cell Death and Differentiation · doi:10.1038/s41418-023-01219-9 · Cited by 91
Tsukamoto, S., Takeuchi, T., Rotinsulu, H., Mangindaan, R. E. P., van Soest, R. W. M., Ukai, K., Kobayashi, H., Namikoshi, M., Ohta, T., & Yokosawa, H. (2008) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2008.10.110 · Cited by 90
Stein, E. M., DeAngelo, D. J., Chromik, J., Chatterjee, M., Bauer, S., Lin, C.-C., Suarez, C., de Vos, F., Steeghs, N., Cassier, P. A., et al. (2022) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-21-1295 · Cited by 90
The E3 ubiquitin ligase Rnf8 stabilizes Tpp1 to promote telomere end protection.
Rai, R., Li, J.-M., Zheng, H., Lok, G. T.-M., Deng, Y., Huen, M. S.-Y., Chen, J., Jin, J., & Chang, S. (2011) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.2172 · Cited by 88 · cited 1×
“In mice, the stabilization of TPP1 at telomeres requires its ubiquitination by the E3 ligase RNF8 [120].”
BackgroundSelf-citationReiner, T., Parrondo, R. D., Pozas, A. D. L., Palenzuela, D. L., & Perez‐Stable, C. (2013) · PLoS ONE · doi:10.1371/journal.pone.0056234 · Cited by 88
Yang, H., Zhang, X., Lao, M., Sun, K., He, L., Xu, J., Duan, Y., Chen, Y., Ying, H., Li, M., et al. (2022) · Cell Death and Differentiation · doi:10.1038/s41418-022-01102-z · Cited by 88
The deubiquitinase USP21 stabilizes MEK2 to promote tumor growth
Li, W., Cui, K., Prochownik, E. V., & Li, Y. (2018) · Cell Death and Disease · doi:10.1038/s41419-018-0523-z · Cited by 87
USP10 suppresses tumor progression by inhibiting mTOR activation in hepatocellular carcinoma
Lu, C., Ning, Z., Wang, A., Chen, D., Liu, X., Xia, T., Tekcham, D. S., Wang, W., Li, T., Liu, X., et al. (2018) · Cancer Letters · doi:10.1016/j.canlet.2018.07.032 · Cited by 87
Asano, N., Imatani, A., Watanabe, T., Fushiya, J., Kondo, Y., Jin, X., Ara, N., Uno, K., Iijima, K., Koike, T., et al. (2016) · Cancer Research · doi:10.1158/0008-5472.can-15-2272 · Cited by 86
USP10 inhibits lung cancer cell growth and invasion by upregulating PTEN
Sun, J. Y., Li, T., Zhao, Y., Huang, L., Sun, H., Wu, H., & Jiang, X. (2017) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-017-3170-2 · Cited by 85
USP48 Stabilizes Gasdermin E to Promote Pyroptosis in Cancer
Ren, Y., Feng, M., Hao, X., Liu, X., Li, J., Li, P., Gao, J., Qi, Q., Du, L., Wang, C., et al. (2023) · Cancer Research · doi:10.1158/0008-5472.can-22-1812 · Cited by 85
Shinji, S., Naito, Z., Ishiwata, S., Ishiwata, T., Tanaka, N., Furukawa, K., Suzuki, H., Seya, T., Matsuda, A., 勝田, 美., et al. (2006) · Oncology Reports · doi:10.3892/or.15.3.539 · Cited by 84
Liu, Y., Xu, Q., Deng, F., Zheng, Z., Luo, J., Wang, P., Zhou, J., Lu, X., Zhang, L., Chen, Z., et al. (2023) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-023-02609-0 · Cited by 84
Bejarano, L., Schuhmacher, A. J., Méndez, M., Megías, D., Blanco‐Aparicio, C., Martínez, S., Pastor, J., Squatrito, M., & Blasco, M. A. (2017) · Cancer Cell · doi:10.1016/j.ccell.2017.10.006 · Cited by 82
SCFFBW7-mediated degradation of Brg1 suppresses gastric cancer metastasis
Huang, L.-Y., Zhao, J., Chen, H., Wan, L., Inuzuka, H., Guo, J., Fu, X., Zhai, Y., Lu, Z., Wang, X., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-06038-y · Cited by 82
Self-citationOTULIN protects the liver against cell death, inflammation, fibrosis, and cancer
Damgaard, R. B., Jolin, H. E., Allison, M. E., Davies, S. E., Titheradge, H. L., McKenzie, A. N. J., & Komander, D. (2020) · Cell Death and Differentiation · doi:10.1038/s41418-020-0532-1 · Cited by 82
The Role of Ubiquitination in NF-κB Signaling during Virus Infection
Song, K., & Li, S. (2021) · Viruses · doi:10.3390/v13020145 · Cited by 82
Yang, Z., Xu, G., Wang, B., Liu, Y., Zhang, L., Jing, T., Tang, M., Xu, X., Jiao, K., Xiang, L., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-25032-5 · Cited by 82
Lockhart, A. C., Bauer, T. M., Aggarwal, C., Lee, C. B., Harvey, R. D., Cohen, R. B., Sedarati, F., Nip, T. K., Faessel, H. M., Dash, A. B., et al. (2018) · Investigational New Drugs · doi:10.1007/s10637-018-0610-0 · Cited by 81
Wu, J., Wenzheng, G., Donghua, W., Guangyu, H., Aiping, Z., & Wu, W. (2018) · Cancer Medicine · doi:10.1002/cam4.1675 · Cited by 81
How VEGF-A and its splice variants affect breast cancer development – clinical implications
Kawas, H. A., Saaid, I., Jank, P., Westhoff, C. C., Denkert, C., Pross, T., Weiler, K. B. S., & Karsten, M. M. (2022) · Cellular Oncology · doi:10.1007/s13402-022-00665-w · Cited by 81
The deubiquitylase Ataxin-3 restricts PTEN transcription in lung cancer cells
Sacco, J. J., Yau, T. Y., Darling, S., Patel, V, Liu, H., Urbé, S., Clague, M. J., & Coulson, J. M. (2014) · Oncogene · doi:10.1038/onc.2013.512 · Cited by 80
Zang, Y., Thomas, S. M., Chan, E. T., Kirk, C. J., Freilino, M. L., DeLancey, H. M., Grandis, J. R., Li, C., & Johnson, D. E. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-1213 · Cited by 80
Park, S. H., Fong, K.-W., Kim, J., Wang, F., Lü, X., Lee, Y., Brea, L. T., Wadosky, K. M., Guo, C., Abdulkadir, S. A., et al. (2021) · Science Advances · doi:10.1126/sciadv.abe2261 · Cited by 80
USP22 controls necroptosis by regulating receptor-interacting protein kinase 3 ubiquitination
Roedig, J., Kowald, L., Juretschke, T., Karlowitz, R., Abhari, B. A., Roedig, H., Fulda, S., Beli, P., & van Wijk, S. J. L. (2020) · EMBO Reports · doi:10.15252/embr.202050163 · Cited by 79
Sequential ubiquitination of p53 by TRIM28, RLIM, and MDM2 in lung tumorigenesis
Jin, J., Lee, G. D., Nam, S. H., Lee, T. H., Kang, D. H., Yun, J. K., & Lee, P. C.-W. (2020) · Cell Death and Differentiation · doi:10.1038/s41418-020-00701-y · Cited by 78
Zhang, H., Xia, Y., Wang, F., Luo, M., Yang, K., Liang, S., An, S., Wu, S., Yang, C., Chen, D., et al. (2021) · Advanced Science · doi:10.1002/advs.202003404 · Cited by 78
Deubiquitinase PSMD14 promotes ovarian cancer progression by decreasing enzymatic activity of PKM2
Sun, T., Liu, Z., Bi, F., & Yang, Q. F. (2021) · Molecular Oncology · doi:10.1002/1878-0261.13076 · Cited by 78
Self-citationIt’s Getting Complicated—A Fresh Look at p53-MDM2-ARF Triangle in Tumorigenesis and Cancer Therapy
Kung, C.-P., & Weber, J. D. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.818744 · Cited by 78
Liu, W., Zheng, M., Zhang, R., Jiang, Q., Du, G., Wu, Y., Yang, C., Li, F., Li, W., Wang, L., et al. (2022) · Advanced Science · doi:10.1002/advs.202203884 · Cited by 78
Yamaguchi, M., Miyazaki, M., Kodrasov, M. P., Rotinsulu, H., Losung, F., Mangindaan, R. E. P., de Voogd, N. J., Yokosawa, H., Nicholson, B., & Tsukamoto, S. (2013) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2013.04.066 · Cited by 77
Yu, B., Liu, Z., Fu, Y., Wang, Y., Zhang, L., Cai, Z., Yu, F., Wang, X., Zhou, J., & Kong, W. (2017) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.117.309859 · Cited by 77
Self-citationChen, Q., Hang, Y., Zhang, T., Tan, L. H., Li, S., & Jin, Y. (2018) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00272.2018 · Cited by 77
Gangula, N. R., & Maddika, S. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.503383 · Cited by 75
Tumor Cell–Intrinsic USP22 Suppresses Antitumor Immunity in Pancreatic Cancer
Li, J., Yuan, S., Norgard, R. J., Yan, F., Yamazoe, T., Blanco, M. A., & Stanger, B. Z. (2020) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-19-0661 · Cited by 75
Li, M., Gao, F., Zhao, Q., Zuo, H., Liu, W., & Li, W. (2020) · Cell Death and Disease · doi:10.1038/s41419-020-2579-9 · Cited by 75
USP15 potentiates NF‐κB activation by differentially stabilizing TAB2 and TAB3
Zhou, Q., Cheng, C., Wei, Y., Yang, J. X., Zhou, W., Song, Q., Ke, M., Yan, W., Zheng, L., Zhang, Y., et al. (2020) · FEBS Journal · doi:10.1111/febs.15202 · Cited by 74
Ubiquitin Ligase RLIM Modulates Telomere Length Homeostasis through a Proteolysis of TRF1
Her, Y. R., & Chung, I. K. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m806702200 · Cited by 73
Ito, H., Nakamae, I., Kato, J., & Yoneda‐Kato, N. (2021) · Journal of Clinical Investigation · doi:10.1172/jci141529 · Cited by 73
Ret finger protein 2 enhances ionizing radiation-induced apoptosis via degradation of AKT and MDM2
Joo, H. M., Kim, J.-Y., Jeong, J. B., Seong, K. M., Nam, S. Y., Yang, K. H., Kim, C. S., Kim, H. S., Jeong, M., An, S., et al. (2011) · European Journal of Cell Biology · doi:10.1016/j.ejcb.2010.12.001 · Cited by 71
A phase I study of perifosine with temsirolimus for recurrent pediatric solid tumors
Becher, O. J., Gilheeney, S. W., Khakoo, Y., Lyden, D. C., Haque, S. S., Braganca, K. C. D., Kolesar, J., Huse, J. T., Modak, S. I., Wexler, L. H., et al. (2016) · Pediatric Blood & Cancer · doi:10.1002/pbc.26409 · Cited by 71
FBXO22 mediates polyubiquitination and inactivation of LKB1 to promote lung cancer cell growth
Zhu, X., He, P., Zhang, L., Yang, S., Zhang, H., Zhu, D., Liu, M.-D., & Yu, Y. (2019) · Cell Death and Disease · doi:10.1038/s41419-019-1732-9 · Cited by 71
Deregulation of SPOP in Cancer
Zhang, H., Jin, X., & Huang, H. (2022) · Cancer Research · doi:10.1158/0008-5472.can-22-2801 · Cited by 71
Zhu, L., Qin, C., Li, T., Ma, X., Qiu, Y., Lin, Y., Ma, D., Qin, Z., Sun, C., Shen, X., et al. (2019) · Cell Death and Differentiation · doi:10.1038/s41418-019-0464-9 · Cited by 69
Wang, W., Li, M., Ponnusamy, S., Chi, Y., Xue, J., Fahmy, B., Fan, M., Miranda‐Carboni, G. A., Narayanan, R., Wu, J., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-17770-9 · Cited by 69
Roquin-2 Promotes Ubiquitin-Mediated Degradation of ASK1 to Regulate Stress Responses
Maruyama, T., Araki, T., Kawarazaki, Y., Naguro, I., Heynen, S., Aza‐Blanc, P., Ronai, Z. A., Matsuzawa, A., & Ichijo, H. (2014) · Science Signaling · doi:10.1126/scisignal.2004822 · Cited by 68
The Many Roles of Ubiquitin in NF-κB Signaling
Courtois, G., & Fauvarque, M. (2018) · Biomedicines · doi:10.3390/biomedicines6020043 · Cited by 68
Zhang, H., Han, B., Lu, H., Zhao, Y., Chen, X., Meng, Q., Cao, M., Cai, L., & Hu, J. (2018) · Cancer Letters · doi:10.1016/j.canlet.2018.07.002 · Cited by 68
Self-citationPD-L1 translocation to the plasma membrane enables tumor immune evasion through MIB2 ubiquitination
Yu, X., Li, W., Liu, H., Wang, X., Coarfa, C., Cheng, C., Yu, X., Zeng, Z., Cao, Y., Young, K. H., et al. (2023) · Journal of Clinical Investigation · doi:10.1172/jci160456 · Cited by 68
USP11 Enhances TGFβ-Induced Epithelial–Mesenchymal Plasticity and Human Breast Cancer Metastasis
Garcia, D. A., Baek, C., Estrada, M. V., Tysl, T., Bennett, E. J., Yang, J., & Chang, J. T. (2018) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-17-0723 · Cited by 67
The pleiotropic effects of the glutamate dehydrogenase (GDH) pathway in Saccharomyces cerevisiae
Mara, P., Fragiadakis, G. S., Gkountromichos, F., & Alexandraki, D. (2018) · Microbial Cell Factories · doi:10.1186/s12934-018-1018-4 · Cited by 67
Molecular predictors of response to pembrolizumab in thymic carcinoma
He, Y., Ramesh, A., Gusev, Y., Bhuvaneshwar, K., & Giaccone, G. (2021) · Cell Reports Medicine · doi:10.1016/j.xcrm.2021.100392 · Cited by 67
Targeting the MDM2-p53 pathway in dedifferentiated liposarcoma
Traweek, R. S., Cope, B. M., Roland, C. L., Keung, E. Z.-Y., Nassif, E. F., & Erstad, D. J. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.1006959 · Cited by 66
Liang, C., Wang, S., Qin, C., Bao, M., Cheng, G., Liu, B., Shao, P., Lv, Q., Song, N., Hua, L., et al. (2018) · Cell Death and Disease · doi:10.1038/s41419-017-0197-y · Cited by 65
Ubiquitination Links DNA Damage and Repair Signaling to Cancer Metabolism
Koo, S.-Y., Park, E., Noh, H.-J., Jo, S.-M., Ko, B.-K., Shin, H.-J., & Lee, C. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24098441 · Cited by 65
Xiao, K., Peng, S., Lu, J., Zhou, T., Hong, X., Chen, S., Liu, G., Li, H., Huang, J., Chen, X., et al. (2023) · Cell Death and Disease · doi:10.1038/s41419-023-05938-2 · Cited by 65
Self-citationYe, M., Chen, J., Lu, F., Zhao, M., Wu, S., Hu, C., Yu, P., Kan, J., Bai, J., Tian, Y., et al. (2023) · Cell & Bioscience · doi:10.1186/s13578-023-01100-9 · Cited by 64 · cited 1×
“Hexokinase 2 (HK2) phosphorylates glucose to produce glucose-6-phosphate (G-6-P), regulating glucose metabolism [330].”
BackgroundSelf-citationPatnaik, A., Tolcher, A. W., Beeram, M., Nemunaitis, J. J., Weiss, G. J., Bhalla, K. N., Agrawal, M., NICHOLS, G. L., Middleton, S. A., Beryozkina, A., et al. (2015) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-015-2830-8 · Cited by 64
Hong, S., Jin, D., Shin, J.-S., Moon, J.-H., Na, Y.-S., Jung, K., Kim, S.-M., Kim, J. C., Kim, K., Hong, Y. S., et al. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.319822 · Cited by 64
Akt phosphorylation at Thr308 and Ser473 is required for CHIP-mediated ubiquitination of the kinase
Su, C.-H., Wang, C.-Y., Lan, K., Li, C., Chao, Y., Lin, H.-C., Lee, S., & Lee, W. (2011) · Cellular Signalling · doi:10.1016/j.cellsig.2011.06.018 · Cited by 64
Ushiyama, S., Umaoka, H., Kato, H., Suwa, Y., Morioka, H., Rotinsulu, H., Losung, F., Mangindaan, R. E. P., de Voogd, N. D., Yokosawa, H., et al. (2012) · Journal of Natural Products · doi:10.1021/np300352u · Cited by 64
McClurg, U. L., Summerscales, E. E., Harle, V. J., Gaughan, L., & Robson, C. N. (2014) · Oncotarget · doi:10.18632/oncotarget.2162 · Cited by 63
Zhang, Y., Zhang, X., Ye, M., Jing, P., Xiong, J., Han, Z., Kong, J., Li, M., Lai, X., Chang, N., et al. (2018) · Cancer Letters · doi:10.1016/j.canlet.2018.01.047 · Cited by 63
Hamilton, E. P., Schott, A. F., Nanda, R., Lu, H., Keung, C. F., Gedrich, R., Parameswaran, J., Han, H. S., & Hurvitz, S. A. (2022) · Journal of Clinical Oncology · doi:10.1200/jco.2022.40.16_suppl.tps1120 · Cited by 63
Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma
Cao, Y., Xie, L., Tong, B.-B., Chu, M.-Y., Shi, W.-Q., Li, X., He, J., Wang, S., Wu, Z., Deng, D.-X., et al. (2022) · Cell Death and Differentiation · doi:10.1038/s41418-022-01104-x · Cited by 63
Gu, J., Mao, W., Ren, W., Xu, F., Zhu, Q., Lu, C., Lin, Z., Zhang, Z., Chu, Y., Liu, R., et al. (2018) · Cancer Letters · doi:10.1016/j.canlet.2018.11.029 · Cited by 62
de Weger, V. A., de Jonge, M., Langenberg, M. H. G., Schellens, J. H. M., Lolkema, M., Varga, A., Demers, B., Thomas, K., Hsu, K., Tuffal, G., et al. (2019) · British Journal of Cancer · doi:10.1038/s41416-018-0355-8 · Cited by 62
Tao, Y., Sun, X.-S., Pointreau, Y., Tourneau, C. L., Sire, C., Kaminsky, M., Coutté, A., Alfonsi, M., Calderon, B., Boisselier, P., et al. (2023) · European Journal of Cancer · doi:10.1016/j.ejca.2022.12.015 · Cited by 62
Pal, D., Sharma, U., Singh, S. K., Kakkar, N., & Prasad, R. (2015) · PLoS ONE · doi:10.1371/journal.pone.0115651 · Cited by 61
Chen, X., Yin, Y., Cheng, J., Huang, A., Hu, B., Zhang, X., Sun, Y., Wang, J., Wang, Y., Ji, Y., et al. (2018) · Cell Death and Disease · doi:10.1038/s41419-018-1087-7 · Cited by 61
Self-citationWu, X., Liu, M., Zhu, H., Wang, J., Dai, W., Li, J., Zhu, D., Tang, W., Xiao, Y., Lin, J., et al. (2019) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-019-1270-4 · Cited by 61
Hamilton, E., Vahdat, L., Han, H. S., Ranciato, J., Gedrich, R., Keung, C. F., Chirnomas, D., & Hurvitz, S. (2022) · Cancer Research · doi:10.1158/1538-7445.sabcs21-pd13-08 · Cited by 61
Therapeutic Potential of Pharmacological Targeting NLRP3 Inflammasome Complex in Cancer
Tezcan, G., Garanina, E. E., Al-Saadi, A., Gilazieva, Z., Martinova, E. V., Markelova, M., Arkhipova, S. S., Hamza, S., McIntyre, A., Rizvanov, A. A., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2020.607881 · Cited by 60
Recent advances on the intervention sites targeting USP7-MDM2-p53 in cancer therapy
Harakandi, C., Nininahazwe, L., Xu, H., Liu, B., He, C., Zheng, Y., & Zhang, H. (2021) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2021.105273 · Cited by 60
Targeting Ferroptosis by Ubiquitin System Enzymes: A Potential Therapeutic Strategy in Cancer
Yu, M., Sun, H., Li, Y., Zhao, S., Su, J., Zeng, F., Deng, G., & Chen, X. (2022) · International Journal of Biological Sciences · doi:10.7150/ijbs.73790 · Cited by 60
Self-citationKim, S., Kim, H., Kang, S. U., Kim, Y. E., Park, J. K., Shin, Y. S., Kim, Y. S., Lee, K., & Kim, C. (2015) · Oncotarget · doi:10.18632/oncotarget.5407 · Cited by 59
Malek, E., Abdel-Malek, M. A. Y., Jagannathan, S., Vad, N. M., Karns, R. A., Jegga, A. G., Broyl, A., van Duin, M., Sonneveld, P., Cottini, F., et al. (2016) · Leukemia · doi:10.1038/leu.2016.258 · Cited by 59
Atypical Ubiquitination and Parkinson’s Disease
Бунеева, О. А., & Medvedev, A. E. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23073705 · Cited by 59
Fang, D. D., Tang, Q., Kong, Y., Rong, T., Wang, Q., Li, N., Fang, X., Gu, J., Xiong, D., Yin, Y., et al. (2021) · Cell Death Discovery · doi:10.1038/s41420-021-00465-5 · Cited by 58 · cited 1×
“APG-115 has shown potent anti-tumor activity in preclinical models of acute myeloid leukemia [472].”
BackgroundSelf-citationLi, T., Wang, X., Ju, E., da Silva, S. R., Chen, L., Zhang, X., Wei, S., & Gao, S. (2021) · Nature Communications · doi:10.1038/s41467-021-21206-3 · Cited by 58
He, Y., Jiang, S., Zhong, Y., Wang, X., Cui, Y., Liang, J., Sun, Y., Zhu, Z., Huang, Z., & Mao, X. (2023) · Clinical and Translational Medicine · doi:10.1002/ctm2.1509 · Cited by 58
Luo, M., Wang, X., Wu, S., Yang, C., Su, Q., Huang, L., Fu, K., An, S., Xie, F., To, K. K. W., et al. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01545-x · Cited by 57
Toxohormone-like Factor from Microorganisms with Impaired Respiration
Callao, V., & Montoya, E. (1961) · Science · doi:10.1126/science.134.3495.2041 · Cited by 56
BimEL is phosphorylated at mitosis by Aurora A and targeted for degradation by βTrCP1
Moustafa-Kamal, M., Gamache, I., Lü, Y., Li, S., & Teodoro, J. G. (2013) · Cell Death and Differentiation · doi:10.1038/cdd.2013.93 · Cited by 56
Jiang, J.-H., Liu, Y., Ke, A., Gu, F., Yao, Y., Dai, Z., Gao, Q., Shi, G., Liao, B., Xie, Y., et al. (2014) · Hepatology · doi:10.1002/hep.27012 · Cited by 55
LUBAC accelerates B-cell lymphomagenesis by conferring resistance to genotoxic stress on B cells
Jo, T., Nishikori, M., Kogure, Y., Arima, H., Sasaki, K., Sasaki, Y., Nakagawa, T., Iwai, F., Momose, S., Shiraishi, A., et al. (2020) · Blood · doi:10.1182/blood.2019002654 · Cited by 55
Niederkorn, M., Ishikawa, C., Hueneman, K. M., Bartram, J., Stepanchick, E., Bennett, J. R., Culver‐Cochran, A. E., Bolanos, L. C., Uible, E. E., Choi, K., et al. (2021) · Leukemia · doi:10.1038/s41375-021-01394-z · Cited by 55
Chargari, C., Leteur, C., Angevin, E., Bashir, T., Schoentjes, B., Arts, J., Janicot, M., Bourhis, J., & Deutsch, E. (2011) · Cancer Letters · doi:10.1016/j.canlet.2011.08.011 · Cited by 54
Potential of E3 Ubiquitin Ligases in Cancer Immunity: Opportunities and Challenges
Ye, P., Chi, X., Cha, J., Luo, S., Yang, G., Yan, X., & Yang, W. (2021) · Cells · doi:10.3390/cells10123309 · Cited by 54
Chen, B., Hong, Y., Gui, R., Zheng, H., Tian, S., Zhai, X., Xie, X., Chen, Q., Qian, Q., Ren, X., et al. (2022) · Cell Death and Disease · doi:10.1038/s41419-022-05245-2 · Cited by 54
USP15 antagonizes CRL4 CRBN -mediated ubiquitylation of glutamine synthetase and neosubstrates
Nguyen, T. V. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2111391118 · Cited by 53
Tan, M., Xu, J., Siddiqui, J., Feng, F. Y.-C., & Sun, Y. (2016) · Molecular Cancer · doi:10.1186/s12943-016-0567-6 · Cited by 52
The roles of ubiquitin modifying enzymes in neoplastic disease
Kumari, N., Jaynes, P. W., Saei, A., Iyengar, P. V., Richard, J. L. C., & Eichhorn, P. J. A. (2017) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2017.09.002 · Cited by 52
Liang, J., Ning, Z., Gao, W., Ling, J., Wang, A., Luo, H., Liang, Y., Yan, Q., & Wang, Z. (2014) · Oncology Reports · doi:10.3892/or.2014.3508 · Cited by 51
USP1 regulates AKT phosphorylation by modulating the stability of PHLPP1 in lung cancer cells
Zhiqiang, Z., Qinghui, Y., Yongqiang, Z., Jian, Z., Xin, Z., Ma, H., & Yue-peng, G. (2012) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-012-1193-3 · Cited by 51
Tyrosine phosphorylation of SHIP promotes its proteasomal degradation
Rüschmann, J., Ho, V. W., Antignano, F., Kuroda, E., Lam, V., Ibaraki, M., Snyder, K., Kim, C., Flavell, R. A., Kawakami, T., et al. (2010) · Experimental Hematology · doi:10.1016/j.exphem.2010.03.010 · Cited by 51
Wang, F. F., Zhang, X. J., Yan, Y., Zhu, X., Yu, J., Ding, Y., Hu, J., Zhou, W., Zeng, Z., Liao, W., et al. (2016) · Cancer Letters · doi:10.1016/j.canlet.2016.11.031 · Cited by 51
Yan, M., Zhao, C., Wei, N., Wu, X., Cui, J., & Xing, Y. (2018) · Medical Science Monitor · doi:10.12659/msm.909235 · Cited by 51
BAP1 suppresses prostate cancer progression by deubiquitinating and stabilizing PTEN
Deng, R., Guo, Y., Li, L., He, J., Qiang, Z., Zhang, H., Chen, R., Wang, Y., Zhao, X., & Yu, J. (2020) · Molecular Oncology · doi:10.1002/1878-0261.12844 · Cited by 51
Ubiquitination and SUMOylation in the chronic inflammatory tumor microenvironment
Chang, S. C., & Ding, J. L. (2018) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2018.08.002 · Cited by 50
Pellino1 regulates reversible ATM activation via NBS1 ubiquitination at DNA double-strand breaks
Ha, G., Ji, J., Chae, S., Park, J., Kim, S., Lee, J., Kim, Y., Min, S., Park, J., Kang, T., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-09641-9 · Cited by 50
The deubiquitinating enzyme USP15 stabilizes ERα and promotes breast cancer progression
Xia, X., Huang, C., Liao, Y., Liu, Y., He, J., Shao, Z., Hu, T., Yu, C., Jiang, L., Liu, J., et al. (2021) · Cell Death and Disease · doi:10.1038/s41419-021-03607-w · Cited by 49
Murphy, M., Xiong, Y., Pattabiraman, G., Qiu, F., & Medvedev, A. E. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.640128 · Cited by 48
Sanders, M. A., Haynes, B. M., Nangia‐Makker, P., Polin, L., & Shekhar, M. P. V. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.m117.792192 · Cited by 48
Pan, W., Luo, Q., Yan, X., Yuan, L., Yi, H., Zhang, L., Li, B., Zhang, Y., Sun, J., Qiu, M., et al. (2018) · Biochemical Pharmacology · doi:10.1016/j.bcp.2018.04.020 · Cited by 48
Yee, K., Papayannidis, C., Vey, N., Dickinson, M. J., Kelly, K. R., Assouline, S., Kasner, M., Seiter, K., Drummond, M. W., Yoon, S.-S., et al. (2021) · Leukemia Research · doi:10.1016/j.leukres.2020.106489 · Cited by 47
mTORC1 Promotes ARID1A Degradation and Oncogenic Chromatin Remodeling in Hepatocellular Carcinoma
Zhang, S., Zhou, Y.-F., Cao, J. P., Burley, S. K., Wang, H., & Zheng, X. (2021) · Cancer Research · doi:10.1158/0008-5472.can-21-0206 · Cited by 47
DNA Damage Response Regulation by Histone Ubiquitination
Sekiguchi, M., & Matsushita, N. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23158187 · Cited by 47
Hou, B., Chen, T., Zhang, H., Li, J., Wang, P., & Shang, G. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1123244 · Cited by 47
Induction of the lysosomal apoptosis pathway by inhibitors of the ubiquitin‐proteasome system
Berndtsson, M., Beaujouin, M., Rickardson, L., Havelka, A. M., Larsson, R. L., Westman, J., Liaudet‐Coopman, E., & Linder, S. T. (2008) · International Journal of Cancer · doi:10.1002/ijc.24004 · Cited by 45
Function of Deubiquitinating Enzyme USP14 as Oncogene in Different Types of Cancer
Zhu, Y., Zhang, C., Gu, C., Li, Q., & Wu, N. (2016) · Cellular Physiology and Biochemistry · doi:10.1159/000443051 · Cited by 45
Self-citationMeng, F., Su, Y., & Xu, B. (2020) · Molecular Oncology · doi:10.1002/1878-0261.12804 · Cited by 45
Liu, W., Ren, D., Xiong, W., Jin, X., & Zhu, L. (2022) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-022-02253-0 · Cited by 45
Jang, H., Hwang, H. Z., Kim, H.-S., & Lee, S. Y. (2019) · Cellular & Molecular Biology Letters · doi:10.1186/s11658-019-0156-y · Cited by 43
E3 ligase MG53 suppresses tumor growth by degrading cyclin D1
Fang, M., Wu, H., Pei, Y., Zhang, Y., Gao, X., He, Y., Chen, G., Lv, F., Jiang, P., Li, Y., et al. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01458-9 · Cited by 43
Augello, G., Modica, M. D., Azzolina, A., Puleio, R., Cassata, G., Emma, M. R., Sano, C. D., Cusimano, A., Montalto, G., & Cervello, M. (2018) · Cell Death and Disease · doi:10.1038/s41419-017-0195-0 · Cited by 42
Italiano, A., Miller, W. H., Blay, J., Gietema, J. A., Bang, Y., Mileshkin, L., Hirte, H. W., Higgins, B., Blotner, S. D., NICHOLS, G. L., et al. (2021) · Investigational New Drugs · doi:10.1007/s10637-021-01141-2 · Cited by 41
Liu, F., Wu, Q., Han, W., Laster, K. V., Hu, Y., Ma, F., Chen, H., Tian, X., Qiao, Y., Liu, H., et al. (2021) · Clinical and Translational Medicine · doi:10.1002/ctm2.548 · Cited by 41
Self-citationThe OX40-TRAF6 axis promotes CTLA-4 degradation to augment antitumor CD8+ T-cell immunity
Yu, J., Cui, J., Zhang, X., Xu, H., Chen, Z., Li, Y., Niu, Y., Wang, S., Ran, S., Zou, Y., et al. (2023) · Cellular and Molecular Immunology · doi:10.1038/s41423-023-01093-y · Cited by 41
Skp1: Implications in cancer and SCF-oriented anti-cancer drug discovery
Hussain, M., Lu, Y., Liu, Y., Su, K., Zhang, J., Liu, J., & Zhou, G. (2016) · Pharmacological Research · doi:10.1016/j.phrs.2016.05.027 · Cited by 40
EZH2–CCF–cGAS Axis Promotes Breast Cancer Metastasis
Duan, D., Shang, M., Han, Y., Liu, J., Liu, J., Kong, S. H., Hou, J., Huang, B., Lü, J., & Zhang, Y. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23031788 · Cited by 40
FBW7 suppresses metastasis of colorectal cancer by inhibiting HIF1α/CEACAM5 functional axis
Li, Q., Li, Y., Li, J., Ma, Y., Dai, W., Mo, S., Xu, Y., Li, X., & Cai, S. (2018) · International Journal of Biological Sciences · doi:10.7150/ijbs.24505 · Cited by 39
Pitarresi, J. R., Liu, X., Avendano, A., Thies, K., Sizemore, G. M., Hammer, A. M., Hildreth, B. E., Wang, J., Steck, S., Donohue, S., et al. (2018) · Life Science Alliance · doi:10.26508/lsa.201800190 · Cited by 39
Self-citationCundiff, M. D., Hurley, C. M., Wong, J. D., Boscia, J., Bashyal, A., Rosenberg, J. A., Reichard, E. L., Nassif, N., Brodbelt, J. S., & Kraut, D. A. (2019) · Scientific Reports · doi:10.1038/s41598-019-50857-y · Cited by 39
Emerging role of RNF2 in cancer: From bench to bedside
Qi, Y., Chen, B., Hu, S., Qi, S., Li, L., Yang, J., Zhou, H., Yang, C., Chen, L., & Du, J. (2021) · Journal of Cellular Physiology · doi:10.1002/jcp.30260 · Cited by 39
Targeting the Lysosomal Degradation of Rab22a‐NeoF1 Fusion Protein for Osteosarcoma Lung Metastasis
Zeng, C., Zhong, L., Liu, W., Zhang, Y., Yu, X., Wang, X., Zhang, R., Kang, T., & Liao, D. (2022) · Advanced Science · doi:10.1002/advs.202205483 · Cited by 39
Ubiquitination by SAG regulates macrophage survival/death and immune response during infection
Chang, S., & Ding, J. L. (2014) · Cell Death and Differentiation · doi:10.1038/cdd.2014.54 · Cited by 38
The F‐box protein FBXL 18 promotes glioma progression by promoting K63‐linked ubiquitination of Akt
Zhang, J., Yang, Z., Ou, J., Xia, X., Zhi, F., & Cui, J. (2016) · FEBS Letters · doi:10.1002/1873-3468.12521 · Cited by 38
Maddalena, F., Condelli, V., Matassa, D. S., Pacelli, C., Scrima, R., Lettini, G., Li Bergolis, V., Pietrafesa, M., Crispo, F., Piscazzi, A., et al. (2020) · Molecular Oncology · doi:10.1002/1878-0261.12814 · Cited by 38
Yao, L., Li, J., Jiang, B., Zhang, Z., Li, X., Ouyang, X., Xiao, Y., Liu, G., Wang, Z., & Zhang, G. (2023) · Cell Death and Disease · doi:10.1038/s41419-023-05785-1 · Cited by 38
Zhang, N., Gao, X., Yuan, Q., Fu, X. J., Wang, P., Cai, F., Liu, H., Zhang, J., Liang, H., Nie, Y., et al. (2023) · Clinical Epigenetics · doi:10.1186/s13148-023-01492-y · Cited by 38
Wang, W., Yang, J., Liao, Y., Cheng, G., Chen, J., Mo, S., Li, Y., Cheng, X., Qin, J., & Shao, Z. (2020) · Journal of Natural Products · doi:10.1021/acs.jnatprod.0c00189 · Cited by 37
Self-citationTAK1 Is a Novel Target in Hepatocellular Carcinoma and Contributes to Sorafenib Resistance
Xia, S., Ji, L., Tao, L., Pan, Y., Lin, Z., Wan, Z., Pan, H., Zhao, J., Cai, L., Xu, J., et al. (2021) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2021.04.016 · Cited by 37
Tian, Y., Liu, K., Liu, R., Qiu, Z., Xu, Y., Wei, W., Xu, X. J., Wang, J., Ding, H., Li, Z., et al. (2022) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.2c00013 · Cited by 37
Self-citationDai, T., Zhang, X., Zhou, X., Hu, X., Huang, X., Xing, F., Tian, H., & Li, Y. (2022) · Clinical and Translational Medicine · doi:10.1002/ctm2.1088 · Cited by 36
The deubiquitinase inhibitor b-AP15 induces strong proteotoxic stress and mitochondrial damage
Zhang, X., Pellegrini, P., Saei, A. A., Hillert, E., Mazurkiewicz, M., Olofsson, M. H., Zubarev, R. A., D’Arcy, P., & Linder, S. T. (2018) · Biochemical Pharmacology · doi:10.1016/j.bcp.2018.08.039 · Cited by 35
Yeh, C., Bellon, M., Wang, F., Zhang, H., Fu, L., & Nicot, C. (2020) · Molecular Cancer · doi:10.1186/s12943-020-01254-x · Cited by 35
Han, J., Zhao, Z., Zhang, N., Yang, Y., Ma, L., Li, F., Zhang, X., Zuo, J., Fan, Z., Wang, Y., et al. (2021) · Aging · doi:10.18632/aging.202414 · Cited by 35
Bauer, S., Demetri, G. D., Halilovic, E., Dummer, R., Meille, C., Tan, D. S. W., Guerreiro, N., Jullion, A., Ferretti, S., Jeay, S., et al. (2021) · British Journal of Cancer · doi:10.1038/s41416-021-01444-4 · Cited by 35
Shao, J., Shi, T., Yu, H. T., Ding, Y., Li, L., Wang, X., & Wang, X. (2021) · The EMBO Journal · doi:10.15252/embj.2020107480 · Cited by 35
Wu, H., Guo, X., Jiao, Y., Wu, Z., & Lv, Q. (2022) · International Journal of Oncology · doi:10.3892/ijo.2022.5434 · Cited by 35
Zhao, X., Zhou, T.-R., Wang, Y., Bao, M., Ni, C., Ding, L., Sun, S., Dong, H., Li, J., & Liang, C. (2023) · Cancer Science · doi:10.1111/cas.15763 · Cited by 35
Zhang, B., Li, M., Huang, P., Guan, X., & Zhu, Y. (2017) · Thoracic Cancer · doi:10.1111/1759-7714.12453 · Cited by 34
Self-citationEpsins 1 and 2 promote NEMO linear ubiquitination via LUBAC to drive breast cancer development
Song, K., Cai, X., Dong, Y., Wu, H., Wei, Y., Shankavaram, U. T., Cui, K., Lee, Y., Zhu, B., Bhattacharjee, S., et al. (2020) · Journal of Clinical Investigation · doi:10.1172/jci129374 · Cited by 34
Clinical Positioning of the IAP Antagonist Tolinapant (ASTX660) in Colorectal Cancer
Crawford, N., Stott, K. J., Sessler, T., McCann, C. K., McDaid, W. J., Lees, A., Latimer, C. H., Fox, J. P., Munck, J. M., Smyth, T., et al. (2021) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-20-1050 · Cited by 34
Yang, H., Xue, M., Su, P., Zhou, Y., Li, X., Li, Z., Xia, Y., Zhang, C., Fu, M., Zheng, X., et al. (2022) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-022-02576-y · Cited by 34
Song, Z., Cao, Q., Guo, B., Ye, Z., Li, X., Lou, N., Zhu, C., Luo, G., Peng, S., Li, G., et al. (2023) · Aging and Disease · doi:10.14336/ad.2023.0202 · Cited by 34
Wang, Q., Chen, Q., Zhu, L., Chen, M., Xu, W., Panday, S., Wang, Z., Li, A., Røe, O. D., Chen, R., et al. (2017) · Oncogenesis · doi:10.1038/oncsis.2017.57 · Cited by 33
Non-Canonical Functions of the ARF Tumor Suppressor in Development and Tumorigenesis
Lаgopati, N., Belogiannis, K., Angelopoulou, A., Papaspyropoulos, A., & Gorgoulis, V. G. (2021) · Biomolecules · doi:10.3390/biom11010086 · Cited by 33
Marsico, M., Santarsiero, A., Pappalardo, I., Convertini, P., Chiummiento, L., Sardone, A., Noia, M. A. D., Infantino, V., & Todisco, S. (2021) · Biomedicines · doi:10.3390/biomedicines9111664 · Cited by 33
Deacetylation of Glutaminase by HDAC4 contributes to Lung Cancer Tumorigenesis
Wang, T., Lü, Z., Han, T., Wang, Y., Gan, M., & Wang, J.-B. (2022) · International Journal of Biological Sciences · doi:10.7150/ijbs.69882 · Cited by 33
Metadata
- Authors
- Liu, F., Chen, J., Li, K., Li, H., Zhu, Y., Zhai, Y., Lu, B., Fan, Y., Liu, Z., Chen, X., Jia, X., Dong, Z., & Liu, K.
- Venue
- Molecular Cancer
- Published
- 2024-07-25
- Volume
- 23
- Issue
- 1
- Pages
- 148-148
- ISSN
- 1476-4598 (ISSN-L)
- OpenAlex
- W4400978852
- Cited by
- 326
- References
- 467
- FWCI
- 37.88
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.